Linezolid tissue penetration and serum activity against strains of methicillin-resistant Staphylococcus aureus with reduced vancomycin susceptibility in diabetic patients with foot infections
Author(s) -
Gary E. Stein,
Sharon Schooley,
Charles A. Peloquin,
Anne E. Missavage,
Daniel Havlichek
Publication year - 2007
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dkm271
Subject(s) - linezolid , vancomycin , medicine , staphylococcus aureus , antimicrobial , micrococcaceae , methicillin resistant staphylococcus aureus , diabetic foot , diabetes mellitus , antibiotics , microbiology and biotechnology , osteomyelitis , antibacterial agent , surgery , bacteria , biology , endocrinology , genetics
Linezolid soft tissue penetration and serum antimicrobial activity were analysed in six patients with peripheral vascular disease and severe diabetic foot infections requiring surgical intervention.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom